MCAM and cancer: Even if the post-translational regulation of CD146 in the fetal brain is clearly far to be understood, this hypothesis could also be plausible since it has been shown in cancer cells that post-translational modifications of CD146 (glycosylation) extends significantly its half-life (Sumardika et al., 2018).